MGX
Price
$1.46
Change
-$0.03 (-2.01%)
Updated
Feb 4, 03:01 PM (EDT)
Capitalization
55.76M
56 days until earnings call
Intraday BUY SELL Signals
XNCR
Price
$11.39
Change
-$0.59 (-4.92%)
Updated
Feb 4, 03:28 PM (EDT)
Capitalization
856.21M
28 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MGX vs XNCR

Header iconMGX vs XNCR Comparison
Open Charts MGX vs XNCRBanner chart's image
Metagenomi Therapeutics
Price$1.46
Change-$0.03 (-2.01%)
Volume$100
Capitalization55.76M
Xencor
Price$11.39
Change-$0.59 (-4.92%)
Volume$2.26K
Capitalization856.21M
MGX vs XNCR Comparison Chart in %
View a ticker or compare two or three
VS
MGX vs. XNCR commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGX is a StrongBuy and XNCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (MGX: $1.49 vs. XNCR: $11.99)
Brand notoriety: MGX and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MGX: 85% vs. XNCR: 64%
Market capitalization -- MGX: $55.76M vs. XNCR: $856.21M
MGX [@Biotechnology] is valued at $55.76M. XNCR’s [@Biotechnology] market capitalization is $856.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MGX’s FA Score shows that 1 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • MGX’s FA Score: 1 green, 4 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, XNCR is a better buy in the long-term than MGX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MGX’s TA Score shows that 4 TA indicator(s) are bullish while XNCR’s TA Score has 3 bullish TA indicator(s).

  • MGX’s TA Score: 4 bullish, 4 bearish.
  • XNCR’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, MGX is a better buy in the short-term than XNCR.

Price Growth

MGX (@Biotechnology) experienced а -10.24% price change this week, while XNCR (@Biotechnology) price change was -8.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +33.05%.

Reported Earning Dates

MGX is expected to report earnings on Apr 01, 2026.

XNCR is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XNCR($856M) has a higher market cap than MGX($55.8M). MGX YTD gains are higher at: -8.025 vs. XNCR (-21.685). XNCR (-85.79M) and MGX (-86.79M) have comparable annual earnings (EBITDA) . XNCR has more cash in the bank: 471M vs. MGX (184M). MGX has less debt than XNCR: MGX (41.7M) vs XNCR (69.3M). XNCR has higher revenues than MGX: XNCR (150M) vs MGX (30.9M).
MGXXNCRMGX / XNCR
Capitalization55.8M856M7%
EBITDA-86.79M-85.79M101%
Gain YTD-8.025-21.68537%
P/E RatioN/AN/A-
Revenue30.9M150M21%
Total Cash184M471M39%
Total Debt41.7M69.3M60%
FUNDAMENTALS RATINGS
XNCR: Fundamental Ratings
XNCR
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
5
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MGXXNCR
RSI
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
65%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
77%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 14 days ago
84%
Bullish Trend 9 days ago
71%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 16 days ago
81%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
68%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
MGX
Daily Signal:
Gain/Loss:
XNCR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AGGWX34.291.45
+4.42%
American Century Global Gold R
MKVGX18.150.08
+0.44%
MFS International Large Cap Value R4
SVXFX80.18N/A
N/A
Smead International Value I1
ADVGX14.02-0.07
-0.50%
North Square Select Small Cap I
PXWEX34.88-0.30
-0.85%
Impax Ellevate Global Women's Ldr Inv

MGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGX has been loosely correlated with CRBU. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MGX jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGX
1D Price
Change %
MGX100%
-3.25%
CRBU - MGX
49%
Loosely correlated
+6.85%
ABSI - MGX
48%
Loosely correlated
+2.32%
PRME - MGX
46%
Loosely correlated
+0.26%
NTLA - MGX
46%
Loosely correlated
-0.08%
XNCR - MGX
45%
Loosely correlated
-0.99%
More

XNCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with CRNX. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XNCR
1D Price
Change %
XNCR100%
-0.99%
CRNX - XNCR
63%
Loosely correlated
+1.24%
DYN - XNCR
58%
Loosely correlated
+1.07%
IDYA - XNCR
58%
Loosely correlated
+0.50%
RCUS - XNCR
57%
Loosely correlated
+1.39%
NUVL - XNCR
57%
Loosely correlated
+2.12%
More